Knight Jeff E.'s Form 4 filing
Crinetics Pharmaceuticals, Inc. (CRNX) · filed Mar 26, 2024
- Accession no.
- 0001209191-24-005081
- Filed
- Mar 26, 2024
- Trade date
- Mar 22, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.43M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Knight Jeff E.CIK 0001881007 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 22, 2024 | Common Stock | MOption exerciseAcquired | +30,000 | $23.98 | +$719,400 | 84,939 | Direct | |
| Mar 22, 2024 | Common Stock | SSaleDisposed | −30,000 | $44.22 | −$1,326,600 | 54,939 | Direct | |
| Mar 22, 2024 | Common Stock | SSaleDisposed | −2,359 | $45.39 | −$107,075.01 | 52,580 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 22, 2024 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 130,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.